1. Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression
   Jia-Nan Cheng et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
2. Myeloid-Derived Suppressor Cells and Cancer Metastasis
   Amene Saghazadeh et al, 2023, Handbook of Cancer and Immunology CrossRef
3. Tumor-targeted gene therapy with lipid nanoparticles inhibits tumor-associated adipocytes and remodels the immunosuppressive tumor microenvironment in triple-negative breast cancer
   Yun Liu et al, 2021, Nanoscale Horizons CrossRef
4. Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy
   Ryotaro Ohkuma et al, 2023, Oncology Letters CrossRef
5. Immunomethylomics: A Novel Cancer Risk Prediction Tool
   Karl T. Kelsey et al, 2018, Annals of the American Thoracic Society CrossRef
6. Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment
   Jihao Zhou et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
7. CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
   Andre Kunert et al, 2019, Journal for ImmunoTherapy of Cancer CrossRef
8. The Immune Regulatory Role of Cytokine-Induced Killer Cells Treatment on Non-Small Cell Lung Cancer Patients
   Li Zhang et al, 2018, Lung Cancer - Strategies for Diagnosis and Treatment CrossRef
9. Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation
   Robert L. Ferris et al, 2018, Cancer Treatment Reviews CrossRef
10. Mechanisms of immune suppression by myeloid-derived suppressor cells: the role of interleukin-10 as a key immunoregulatory cytokine
    Mahmoud Mohammad Yaseen et al, 2020, Open Biology CrossRef
11. The prognostic effects of circulating myeloid-derived suppressor cells in non-small cell lung cancer: systematic review and meta-analysis
    Giuseppe Bronte et al, 2022, Clinical and Experimental Medicine CrossRef
12. Monocytes and Macrophages in Cancer: Unsuspected Roles
    Sofia Gouveia-Fernandes, 2020, Tumor Microenvironment CrossRef
13. Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1
    Karolina Okła et al, 2020, Journal of Translational Medicine CrossRef
14. Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices
    Asmaa M. Zahran et al, 2021, Journal of Immunology Research CrossRef
15. High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis
    Giuseppe Bronte et al, 2022, Frontiers in Immunology CrossRef
16. Functional Flow Cytometry to Predict PD‐L1 Conformational Changes
    Roser Salvia et al, 2023, Current Protocols CrossRef